Trial Profile
Study of the improvement effect of potassium competitive acid blocker and proton pump inhibitors on symptoms in patients with reflux esophagitis (RE): a randomized comparative study of vonoprazan 20mg vs. rabeprazole 10mg using the time (number of days) to improvement in symptoms as an index
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Feb 2015
Price :
$35
*
At a glance
- Drugs Rabeprazole (Primary) ; Vonoprazan (Primary)
- Indications Reflux oesophagitis
- Focus Therapeutic Use
- 28 Feb 2015 New trial record